Optimization of Recombinant Antibody Production in CHO Cells
The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. Multiple strategies are employed maximize antibody titer, comprising process parameter optimization, cell line development, and implementation of perfusion technologies. Fine-tuning growth pa